Insider Transactions Reported by 24 Insiders of Surrozen, Inc./DE

Symbol
SRZN, SRZNW on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Surrozen, Inc./DE executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Tim Kutzkey Director, 10%+ Owner $40,518,415 +$4,685,382 +13% 04 Dec 2025
COLUMN GROUP III GP, LP 10%+ Owner $40,518,415 +$16,685,373 +70% 04 Dec 2025
Benny Soffer Former Director $716,300 11 Aug 2021
Consonance Life Sciences Former 10% Holder $716,300 11 Aug 2021
Kevin Livingston Former Chief Financial Officer $716,300 11 Aug 2021
Yang Li Exec. Vice President, Research $336,462 -$22,209 -6.2% 02 Jan 2026
Charles Williams Chief Operating Officer $257,890 -$31,109 -11% 02 Jan 2026
Craig C. Parker Chief Executive Officer, Director $69,559 15 Dec 2025
Geertrui Vanhove Chief Medical Officer $12,317 15 Dec 2022
Jennifer Jarrett Former Director $11,400 11 Aug 2021
Donald J. Santel Former Director $11,400 11 Aug 2021
Christopher Haqq Former Director $11,400 11 Aug 2021
Yeh Wen-Chen Chief Scientific Officer $10,342 15 Jun 2023
Mace Rothenberg Director 14 May 2025
Anna Berkenblit Director 14 May 2025
ERIC BJERKHOLT Director 14 May 2025
Gad Soffer Former Chief Executive Officer 11 Aug 2021
MITCHELL BLUTT 10%+ Owner 14 Dec 2022
CHRISTOPHER CHAI Director 14 May 2025
Joshua Cory House Former VP Business Development 11 Aug 2021
DAVID J. WOODHOUSE Director 14 May 2025
Shao-Lee Lin Director 14 May 2025
Andrew Pedrum Maleki Chief Financial Officer 12 Nov 2025
Mary Haak-Frendscho Director 14 May 2025

Recent Insider Transactions by Companies or Individuals for Surrozen, Inc./DE

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.